Federal Register / Vol. 72, No.
116 / Monday, June 18, 2007 / Notices 33507
Dated: June 7, 2007.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation (OSDP), Office of the Assistant
Secretary for Planning and Evaluation.
[FR Doc. 07–2980 Filed 6–15–07; 8:45 am]
BILLING CODE 4151–05–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers of Disease Control and
Prevention
[Docket Number NIOSH 105]
Notice of Request for Public To Submit
Comments and Attend Public Meeting
AGENCY: National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice.
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the following meeting and
request for public comment on the
following draft document: ‘‘NIOSH
Hazardous Drugs List Update.’’
The documents can found at: http://
www.cdc.gov/niosh/topics/hazdrug/
2007publicmeeting.
Public Comment Period: Comments
must be postmarked by September 20,
2007. Comments may be submitted
electronically to niocindocket@cdc.gov
or to Diane Miller, Robert A. Taft
Laboratories, 4676 Columbia Parkway,
MS C–34, Cincinnati, Ohio 45226.
Comments should reference the NIOSH
Docket Number 105.
Meeting Date and Time: August 28,
2007 9 a.m.–5 p.m.
Place: Marriott Metro Center Hotel,
775 12th Street, NW., Washington, DC
20005.
Purpose of Meeting: To discuss and
obtain comments on the draft document,
‘‘NIOSH Hazardous Drugs List Update.’’
Special emphasis will be placed on
discussion of the following:
(1) The appropriateness and relevancy
of the NIOSH definition of Hazardous
Drugs;
(2) the appropriateness and relevancy
of the drugs that fit the NIOSH
definition; and
(3) the appropriateness and relevancy
jlentini on PROD1PC65 with NOTICES
of the drugs that do not fit the NIOSH
definition.
Status: The forum will include
scientists and representatives from
various government agencies, industry,
VerDate Aug<31>2005 18:19 Jun 15, 2007 Jkt 211001
labor, and other stakeholders, and is
open to the public, limited only by the
space available. Persons interested in
providing comments need to notify
Diane Miller by July 20, 2007. Ms.
Miller can be reached by telephone at
(513) 533–8450 or by e-mail at
niocindocket@cdc.gov. Persons wanting
to provide comments will be permitted
up to 10 minutes, subject to available
time. If additional time becomes
available, presenters will be notified.
Oral comments given at the meeting will
be recorded and included in the docket.
Written comments will also be accepted
at the meeting. NIOSH will use this
information to help assess and revise
the definition and/or list of Hazardous
Drugs.
Contact for Technical Information:
Barbara MacKenzie, NIOSH, Robert A.
Taft Laboratories, 4676 Columbia Pkwy.
MS C–26, Cincinnati, OH 45226,
Telephone 513–533–8132, e-mail
hazardousdrugs@cdc.gov.
Contact Person for Submitting
Comments/Meeting Attendance: Diane
Miller, Robert A. Taft Laboratories, 4676
Columbia Parkway, MS C–34,
Cincinnati, Ohio 45226, telephone (513)
533–8450. All material submitted to the
Agency should reference docket number
NIOSH 105.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Cincinnati, Ohio 45226.
Dated: June 11, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E7–11680 Filed 6–15–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Statement of Organization, Functions
and Delegation of Authority
Notice is hereby given that I have
redelegated to the TANF Regional
Program Managers the following
authorities vested in me by the Director,
Office of Family Assistance (OFA) in the
memoranda dated April 17, 2007.
(a) Authorities Delegated
1. The authority to respond to general
inquiries about established state,
territorial, and tribal programs, to
explain existing program policies, and
to suggest referrals to other government
agencies and private organizations.
PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\18JNN1.SGM
2. The authority to request
information from state, territorial, and
tribal grantees relative to program
policies and operations.
3. The authority to deem state TANF
plan amendments as complete.
4. The authority to approve or
disapprove state requests, as permitted
under section 45 CFR 205.56(d), to
utilize alternative data-matching sources
for the Income Eligibility Verification
System (IEVS).
5. The authority to approve or
disapprove state IEVS targeting plans,
pursuant to section 45 CFR 205.56(a)(1).
6. The authority to issue letters to
state and tribal TANF grantees
acknowledging their success in
achieving work participation rates for a
fiscal year.
7. The authority to advise and notify
state TANF grantees concerning their
applications for caseload reduction
credits.
8. The authority to request caseload
and expenditure data from state TANF
grantees in order to establish a Tribal
Family Assistance Grant (TFAG).
9. The authority to approve, request
changes, or defer action on ‘‘Letters of
Intent’’ submitted by tribal applicants
who wish to operate a TANF program.
10. The authority to develop TANF
technical assistance plans and proposals
for the expenditure of technical
assistance funds.
11. The authority to request
additional information and consult with
states and tribes on modifications to
TANF corrective compliance plans
submitted in response to a penalty
determination.
12. The authority to serve as
Approving Officials for audit resolution
for state and tribal TANF programs, and
for tribal NEW programs and Adult
Assistance programs that do not involve
cost disallowances.
13. The authority to approve Adult
Assistance program plans and plan
amendments.
14. The authority to approve Federal
Financial Participation (FFP) in
payments for repairs to homes owned by
recipients of assistance under the Adult
Assistance programs.
(b) Limitations
1. This delegation of authority shall
be exercised under the Department’s
existing policies on delegations and
regulations.
2. The authority to respond to general
inquiries relative to established state,
territorial, and tribal programs or to
inquire about specific grantee policies
and operations requires prior
consultation with and concurrence of
the Director, Division of State TANF
18JNN1
 33508 Federal Register / Vol. 72, No. 116 / Monday, June 18, 2007 / Notices
Policy for state TANF and Adult
Assistance topics or the Director,
Division of Tribal TANF Management
for tribal TANF and NEW topics.
3. The authority to deem state TANF
plan amendments complete requires
prior consultation with and concurrence
of the Director, Division of State TANF
Policy.
4. The authority to approve/
disapprove under 45 CFR 205.55(d),
state applications to use alternate
sources of information for income and
eligibility (i.e., IEVS), requires prior
consultation with and the concurrence
of the Office of the Deputy Assistant
Secretary for Administration, the
Director, Division of State TANF Policy,
and with the other programs affected by
the request.
5. The authority to approve/
disapprove under 45 CFR 205.56(a)(1),
IEVS targeting plans, requires prior
consultation with and the concurrence
of the Office of the Deputy Assistance
Secretary for Administration and the
Director, Division of State TANF Policy.
6. The authority to issue letters to
state and tribal TANF grantees
acknowledging their success in
achieving work participation rates for a
fiscal year requires the concurrence of
the Director, Division of State TANF
Policy for state TANF grantees or the
Director, Division of Tribal TANF
Management for tribal TANF grantees.
7. The authority to advise and notify
state TANF grantees on their caseload
reduction credit applications requires
prior consultation with the Director,
Division of State TANF policy.
8. The authority to request caseload
and expenditure data from state TANF
grantees relative to establishing a TFAG
requires consultation with and
concurrence of the Director, Division of
Tribal TANF Management.
9. The authority to approve, request
changes, or defer action on ‘‘Letters of
Intent’’ submitted by tribal applicants
who wish to operate TANF programs
requires prior consultation with and
concurrence of the Director, Division of
Tribal TANF Management.
10. The authority to implement TANF
technical assistance plans and proposals
for the expenditure of technical
assistance funds requires approval of
the Associate Director, TANF in
consultation with the Director, Division
of State & Territory Management.
11. The authority to request
additional information and consult with
jlentini on PROD1PC65 with NOTICES
states and tribes on modifications to
TANF corrective compliance plans
requires prior consultation with and
concurrence of the Director, Division of
State TANF Policy for state TANF plans
VerDate Aug<31>2005 18:19 Jun 15, 2007 Jkt 211001
or the Director, Division of Tribal TANF
Management for tribal TANF plans.
12. The authority to approve audit
resolutions letters requires prior
consultation with and the concurrence
of the Regional Office Grants Officer and
the Director, Division of State TANF
Policy for state TANF and Adult
Assistance grantees, or the Director,
Division of Tribal TANF Management
for tribal TANF and NEW grantees.
13. This delegation of authority does
not include the authority to make
determinations on state appeals
concerning audit questions or
recommendations by the Department of
Health and Human Services (HHS)
Audit Agency which involve ACF
program practices reviewed under titles
I, X, XI, and XVI of the Social Security
Act.
14. The authority to approve Adult
Assistance Plans and amendments
requires prior consultation with and
concurrence of the Director, Division of
State TANF Policy.
15. The authority to approve FFP in
payments for repairs to homes owned by
recipients of Adult Assistance requires
prior consultation with and concurrence
of the Regional Office Grants Officer and
Director, Division of State TANF Policy.
(c) Effective Date
This delegation is effective upon the
date of signature.
(d) Effect on Existing Delegations
As related to the authorities delegated
herein, this delegation of authority
supersedes all previous delegations of
authority to the TANF Regional Program
Managers.
I hereby affirm and ratify any actions
taken by the TANF Regional Office
Program Managers, Office of Family
Assistance, which involved the exercise
of the authorities delegated herein prior
to the effective date of this delegation.
Dated: June 8, 2007.
Katherine Bradley,
Associate Director, TANF.
[FR Doc. E7–11707 Filed 6–15–07; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N–0225]
Anthrax Vaccines—Bridging
Correlates of Protection in Animals to
Immunogenicity in Humans; Public
Workshop
AGENCY: Food and Drug Administration,
HHS.
PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\18JNN1.SGM
ACTION: Notice of public workshop.
The Food and Drug Administration
(FDA) is announcing a public workshop
entitled ‘‘Anthrax Vaccines—Bridging
Correlates of Protection in Animals to
Immunogenicity in Humans.’’ The
purpose of the public workshop is to
discuss possible strategies for bridging
animal efficacy data to human
immunogenicity data for investigational
anthrax vaccines.
Date and Time: The public workshop
will be held on November 8, 2007, from
8:30 a.m. to 5 p.m. and November 9,
2007, from 8:30 a.m. to 1 p.m.
Location: Hilton Washington DC
North/Gaithersburg, 620 Perry Pkwy.,
Gaithersburg, MD, 20877, 1–301–977–
8900.
Contact Person: Pier Minor, National
Institutes of Health/Office of the
Director, 6610 Rockledge Dr., Rm.
5WS6, Mail Stop Code 6604, Bethesda,
MD 20892, 301–451–6809, FAX: 301–
402–0659, e-mail: minorp@mail.nih.gov.
Registration: Mail or fax your
registration information (including
name, title, firm name, address,
telephone, and fax number) to the
contact person by October 19, 2007.
There is no registration fee for the
public workshop. Early registration is
recommended because seating is
limited. There will be no onsite
registration.
If you need special accommodations
due to a disability, please contact
Wenda Minor (see Contact Person) at
least 7 days in advance.
SUPPLEMENTARY INFORMATION: FDA’s
Center for Biologics Evaluation and
Research, in cooperation with the
National Institutes of Health and the
Department of Health and Human
Services’ Office of Biomedical
Advanced Research and Development
Authority (BARDA) within the Office of
the Assistant Secretary for Preparedness
and Response, is holding this public
workshop. The public workshop will
include discussions on: (1) Background
information on the ‘‘Animal Rule’’ (May
31, 2002, 67 FR 37988), immunological
correlates of protection, and the toxin
neutralizing assay that will be used to
assess anthrax vaccine immunogenicity
in animals and humans; (2) animal
protection data for anthrax vaccines
given both pre- and post-exposure; and
(3) human immunogenicity data for
anthrax vaccines. The goal of the public
workshop is to discuss ways to expedite
the development of new anthrax
vaccines by providing additional
information about bridging animal
protection data to human
immunogenicity.
18JNN1